Results of search for 'au:"Dore G "' › Hepatitis SA Library catalogue

Refine your search

Availability
- Limit to currently available items
Authors
- Clackett S (2)
- Dore G (12)
- Dore G J (1)
- Grebely J (2)
- Hobday S (1)
- Marshalla A D (3)
- Rance J (3)
- Stafford F (3)
- Temple-Smith M (3)
- Treloar C (1)
- Valerio H (3)
- Valerio H; Marshall A D; Conway A; Treloar C; Carter L; Marinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prian B; Alavi M; Dore G J; Grebely J; (1)
- Yousafzai M T (1)
- Show more
- Show less
Item types
- Book/report (2)
- Online book/report (1)
- Online journal/article (10)
Locations
- Bookshelves (2)
- Online (11)
Series
- Annals of Internal Medicine (1)
- Drug and Alcohol Dependence (1)
- Drug and Alcohol Review (1)
- Hepatology Communications (1)
- International Journal of Drug Policy (2)
- Medical Journal of Australia (2)
- Protocol number: VHCRP1302 (1)
- UNSW Opinion (1)
- Viruses (1)
- Show more
- Show less
Topics
- Aboriginal/Torres Strait Islanders (1)
- Correctional services (2)
- General handbooks (5)
- Health/mental health sector education (2)
- Injecting drug use transmission (4)
- Medical treatment (7)
- Tests/procedures (1)
- Women (1)
- Show more
- Show less

	1.	Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs : The ETHOS engage study by Valerio H; Marshall A D; Conway A; Treloar C; Carter L; Marinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prian B; Alavi M; Dore G J; Grebely J Series: International Journal of Drug Policy ; Vol. 127London Elsevier 2024 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	2.	Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016–2021 by Carson J Barbieri S Matthews G Dore G Hajarizadeh B Series: Hepatology Communications ; Vol. 7 (4)Alphen aan den Rijn Wolters Kluwer Health Inc. 2023 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	3.	Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia : The ETHOS engage study by Hobday S Valerio H Treloar C Dore G Grebely J et al Series: Drug and Alcohol ReviewMelbourne Wiley Online 2023 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	4.	Timely hepatitis C RNA testing and treatment in the era of direct-acting antiviral therapy among people with hepatitis C in New South Wales, Australia by Yousafzai M T Alavi M Valerio H Hajarizadeh B Grebely J Dore G J Series: Viruses ; Vol.14 (7) Basel Swi. MDPI 2022 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	5.	Reinfection and risk behaviors after treatment of hepatitis C virus infection in persons receiving Opioid Agonist Therapy – a cohort study by Grebely J Dore G J Altice F L Et al Series: Annals of Internal Medicine ; Epub 9/9/2022Philadelphia American College of Physicians 2022 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	6.	Prescribing of direct-acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program by Stafford F Dore G Clackett S Et al Series: Medical Journal of AustraliaSydney AMPCo 2021 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	7.	Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialist - the practitioner experience by Marshalla A D Grebely J Dore G Treloar C Series: Drug and Alcohol Dependence ; 206Amsterdam Elsevier 2020 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	8.	Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting by Rance J Grebely J Dore G J et al Series: International Journal of Drug Policy ; Vol. 77London Elsevier 2020 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	9.	STOP C surveillance and treatment of prisoners with hepatitis C : a study to assess the feasibility of HCV treatment as prevention with interferon-free Direct Acting Antivirals (DAAs) in the prison setting by Dore G Lloyd A Series: Protocol number: VHCRP1302Sydney Kirby Institute 2019 Online resources: Link to source page Direct link to protocol PDF Availability: Items available for loan: Library (1).
	10.	Eliminating hepatitis C over the next decade by Dore G Series: UNSW OpinionSydney University of NSW 2016 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 3.1.
	11.	Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study by White B Dore G Lloyd A Series: Medical Journal of AustraliaSydney AMPCo 2015 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 2.1.
	12.	Hepatitis C: An expanding perspective by Dore G Temple-Smith M Lloyd A Melbourne IP Communications 2009 Availability: Items available for loan: Library (1)Call number: 0.1 ; 057.
	13.	Hepatitis B in Australia: responding to a diverse epidemic by Dore G et al Sydney ACT-HBV 2005 Availability: Items available for loan: Library (1)Call number: 0.1 ; 068.

Refine your search

Availability

Authors

Item types

Locations

Series

Topics

Your search returned 13 results.